Collagen News and Research

Latest Collagen News and Research

Galapagos initiates phase II clinical study of GLPG0259 drug in RA patients

Galapagos NV announced today that it has started a Phase II clinical study for the Company's flagship program GLPG0259, a novel drug being developed for rheumatoid arthritis. In this clinical trial, the safety and efficacy of this novel candidate drug will be tested in RA patients. Galapagos plans to announce interim results by the middle of next year and complete the trial by the end of 2011.

28 Sep 2010

Oxygen Biotherapeutics to showcase DERMACYTE oxygen-rich skin care products at Spa & Resort expo

Oxygen Biotherapeutics, Inc. will showcase for the first time its DERMACYTE oxygen-rich skin care products at the Spa & Resort/Medical Aesthetics Spa Conference and Expo at the Jacob K. Javits Convention Center in New York City starting tomorrow.

28 Sep 2010

Calcitonin combination therapy may help treat osteoarthritis: Study

Tarsa Therapeutics, Inc. and Unigene Laboratories, Inc. today reported preclinical data showing that calcitonin may have synergistic effects in combination with other drugs in reducing the collagen degradation associated with osteoarthritis.

27 Sep 2010

Merus partners with Innocoll to launch 3 advanced wound care products in Canada

Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.

22 Sep 2010

Orthovita publishes clinical data from IDE pilot studies

Orthovita, Inc., an orthobiologics and biosurgery company, is pleased to announce the publication of "Clinical Experience Using Cortoss for Treating Vertebral Compression Fractures with Vertebroplasty and Kyphoplasty" in the September 15, 2010 edition of Spine.

21 Sep 2010

Cornea and Laser Eye Institute to study CXL effectiveness in keratoconus patients

The Cornea and Laser Eye Institute, with Principal Investigator, Peter S. Hersh M.D., is conducting a research study to study the safety and effectiveness of corneal collagen crosslinking (CXL) using Riboflavin/Dextran and Hypotonic Riboflavin in patients with progressive keratoconus and corneal ectasia.

17 Sep 2010

AIAM offers Skin Sculpting Technique training with Dermasculpt smooth-tip microcannula

The latest trend among European doctors, a non-bruising & virtually painless injection technique for fillers using an FDA approved, FLEXIBLE smooth-tip 27G 1 ½" microcannula instead of a sharp needle has now made its way to this side of the Atlantic.

16 Sep 2010

Enlarged hearts regress faster in elderly women than in men after aortic valve replacement

Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to research reported in a surgical supplement of Circulation: Journal of the American Heart Association.

14 Sep 2010

NovaSterilis issued US patent

NovaSterilis Inc. has been issued US Patent # 7,771,652 B2 for “Combined Use of an Alkaline Earth Metal Compound and a Sterilizing Agent to Maintain Osteoinduction Properties of a Demineralized Bone Matrix”

9 Sep 2010

Cachexia reduces function and changes muscle structure of heart in mice with colon cancer

The wasting disease associated with some cancers that is typically seen affecting skeletal muscles can also cause significant damage to the heart, new research in mice suggests.

9 Sep 2010

Scientists discover molecular gatekeeper for arthritis

Elimination of a molecular gatekeeper leads to the development of arthritis in mice, scientists report in a study published in the Journal of Experimental Medicine. The newly discovered gatekeeper is a protein that determines the fate survival or death of damaging cells that mistakenly attack the body's own tissues and lead to autoimmune disorders such as arthritis.

9 Sep 2010

Quick-Med expands and strengthens NIMBUS technology intellectual property

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 7,790,217 entitled "Method of Attaching an Antimicrobial Cationic Polyelectrolyte to the Surface of a Substrate."

8 Sep 2010

STAAR Surgical's Visian Implantable Collamer Lens featured prominently at 2010 ESCRS Congress

STAAR Surgical Company, the leading worldwide developer, manufacturer and marketer of phakic intraocular lenses, today announced that the Visian Implantable Collamer® Lens (ICL) was featured prominently in more than 40 presentations by leading ophthalmologists at meetings prior to and during the 2010 Congress of European Society of Cataract and Refractive Surgeons (ESCRS) held in Paris, France from September 4 through 8, 2010.

8 Sep 2010

Research finds immune system mechanism to minimize collateral damage

A study published today in the journal Science shows how our bodies try to minimise potential 'collateral damage' caused by our immune system when fighting infection. The research may also provide new clues to why cigarette smoke is a significant risk factor for developing diseases of the lung such as chronic bronchitis and emphysema.

3 Sep 2010

Murad launches Hydro-Dynamic Ultimate Moisture for dry, dehydrated skin

Murad, Inc. has announced the launch of Hydro-Dynamic Ultimate Moisture, an uber-rich, all purpose moisturizer that combines an extraordinarily luxurious recipe of ingredients to quench dry, dehydrated skin and restore youthful resilience and tone.

3 Sep 2010

Study shows DERMACYTE Oxygen Concentrate improves skin appearance

Oxygen Biotherapeutics, Inc. today announced that results from an 8-week cosmetic study showed that the topical application of DERMACYTE Oxygen Concentrate, an oxygen-rich skin care lotion, appears to improve the appearance of fine lines and the perception of skin appearance.

31 Aug 2010

David Mosser to discuss primary duty of macrophages at American Physiological Society conference

The term "macrophage" conjures images of a hungry white blood cell gobbling invading bacteria. However, macrophages do much more than that. Not only do they act as antimicrobial warriors, they also play critical roles in immune regulation and wound-healing. They can respond to a variety of cellular signals and change their physiology in response to local cues.

27 Aug 2010

Researchers show biosynthetic cornea can stimulate regeneration in damaged eye tissue

A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans.

26 Aug 2010

FibroGen announces study results of recombinant human type III collagen in corneal damage

FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.

26 Aug 2010

'Pre-vascularization' of device prior to implantation sustains circulation and suppresses scar formation

By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).

24 Aug 2010

Collagen News and Research

Latest Collagen News and Research

Galapagos initiates phase II clinical study of GLPG0259 drug in RA patients

Oxygen Biotherapeutics to showcase DERMACYTE oxygen-rich skin care products at Spa & Resort expo

Calcitonin combination therapy may help treat osteoarthritis: Study

Merus partners with Innocoll to launch 3 advanced wound care products in Canada

Orthovita publishes clinical data from IDE pilot studies

Cornea and Laser Eye Institute to study CXL effectiveness in keratoconus patients

AIAM offers Skin Sculpting Technique training with Dermasculpt smooth-tip microcannula

Enlarged hearts regress faster in elderly women than in men after aortic valve replacement

NovaSterilis issued US patent

Cachexia reduces function and changes muscle structure of heart in mice with colon cancer

Scientists discover molecular gatekeeper for arthritis

Quick-Med expands and strengthens NIMBUS technology intellectual property

STAAR Surgical's Visian Implantable Collamer Lens featured prominently at 2010 ESCRS Congress

Research finds immune system mechanism to minimize collateral damage

Murad launches Hydro-Dynamic Ultimate Moisture for dry, dehydrated skin

Study shows DERMACYTE Oxygen Concentrate improves skin appearance

David Mosser to discuss primary duty of macrophages at American Physiological Society conference

Researchers show biosynthetic cornea can stimulate regeneration in damaged eye tissue

FibroGen announces study results of recombinant human type III collagen in corneal damage

'Pre-vascularization' of device prior to implantation sustains circulation and suppresses scar formation

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Collagen News and Research

Latest Collagen News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in